Chinese E-cigarette Export to Poland in April 2024 Data

Industry Insight by 2FIRSTS
Jun.07.2024
Chinese E-cigarette Export to Poland in April 2024 Data
China's e-cigarette exports to Poland in April 2024 dropped in value but increased in volume, according to trade data.

According to the latest trade data released by the General Administration of Customs, 2FIRSTS has compiled the e-cigarette exports from China to Poland in April 2024. The specifics are as follows:

4月中国出口波兰电子烟约1269万美元 环比下降3.45%

 

The export volume was approximately $12.69 million, a decrease of 3.45% compared to the previous period, and a decrease of 19.54% compared to the same period last year.

 

4月中国出口波兰电子烟约1269万美元 环比下降3.45%

 

The export volume reached approximately 191 tons, showing a month-on-month increase of 9.85% but a year-on-year decrease of 16.85%.

4月中国出口波兰电子烟约1269万美元 环比下降3.45%

 

The export unit price is $66.53 per kilogram, a decrease of 12.1% on a monthly basis and a decrease of 3.2% compared to the same period last year; the average price of "e-cigarettes and similar personal electronic vaporization devices" is $13.97 per unit.

4月中国出口波兰电子烟约1269万美元 环比下降3.45%

 

Among them, "e-cigarettes and similar personal electronic vaporization devices" accounted for 52.4% of the export category, while "products containing nicotine, not made from tobacco or reconstituted tobacco, for non-combustible inhalation" accounted for 47.6%.

4月中国出口波兰电子烟约1269万美元 环比下降3.45%

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Belarus plans to tighten licensing for e-cigarette and e-liquid trade; Lukashenko expresses support
Belarus plans to tighten licensing for e-cigarette and e-liquid trade; Lukashenko expresses support
A report says Belarus plans to tighten, at the legislative level, the licensing of trade in electronic cigarettes and related mixtures (e-liquids). The draft law was discussed at a meeting chaired by President Alexander Lukashenko with the leadership of the Council of Ministers, according to a BelTA correspondent.
Feb.06 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
JTI appoints Olesja Flores as General Manager for Global Travel Retail
JTI appoints Olesja Flores as General Manager for Global Travel Retail
Japan Tobacco International (JTI) has appointed veteran executive Olesja Flores as General Manager, Global Travel Retail. Flores, who has spent more than 25 years at JTI and most recently served as General Manager for the Swiss market, will be based in Dubai and oversee the company’s global travel retail business.
Jan.23 by 2FIRSTS.ai
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
The Philippine Department of Health reiterated Saturday that vaping should not be promoted as an alternative to cigarette smoking, Health Secretary Teodoro “Ted” Herbosa said in a radio interview, according to the Tribune. Herbosa said both vaping and smoking pose irreversible health risks and cited E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI), claiming it led to the death of a 22-year-old male with no smoking history in 2025.
Feb.28 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24